Abiopharma

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission

Perimeter Solutions Announces Proposed Offering of $550 Million Senior Secured Notes

Trinseo - Trinseo Announces Receipt of Notice of Non-Compliance With NYSE Continued Listing Requirements

Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer

Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering

Trinseo Announces Receipt of Notice of Non-Compliance With NYSE Continued Listing Requirements

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadics Recombinant Growth Factors and Media Proteins

Zoetis - Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering

Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering